The Competition Committee has fined the dietary supplement manufacturer Mo’jiza Honeymoon, according to a statement from the regulatory authority.
The committee's office in the Fergana region took note of the company's product advertising. It claimed to promote the recovery of patients, which the agency interpreted as statements regarding the supposed medicinal properties of the products.
It was noted that the promotional materials included references to specific cases of improvement in the conditions of individuals who consumed the product. The regulatory authority deemed these as violations of advertising legislation requirements.
The special commission initiated a case against Mo’jiza Honeymoon and decided to impose a financial penalty on the company. It was also ordered to rectify the violations and implement measures to prevent their recurrence in the future.
In November 2024, the agency issued a warning regarding the advertising of dietary supplements and other products not registered as medicines. Their manufacturers were accused of promoting self-medication, which can often lead to “tragic consequences.”
In the previous ten months, around 1,000 complaints related to the advertising and sale of dietary supplements were reviewed. Consumers were compensated 118 million sums for material damages.
Earlier, Spot reported that 15 tour operators were fined for advertising umra without a license.